Oncolytics biotech inc

Major-Pharmaceuticals

ONCY


1167 Kensington Crescent NW
Calgary , AB T2N 1X7

Executive/
Director

Price

  • Last Close
  • $ 0.89
    $ +0.01 1.6 %
    Dec 6, 2024
  • 52-Week High/Low
  • $2.4 - $0.89
  • YTD
  • -34.1%

  • Trading Volume
  • 7,410
  • Market Cap Full
  • $ 54.6M
  • Shares Outstanding
  • 61.3M
    Dec 31, 2022
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 39.6% - - - 2.8% -5% 60.1% 12.9% -26.4% -21.5%
Q2 -32.4% -94.7% -94.7% -12.1% -9.2% 4% -27.3% -36.1% 116.7% 0.9%
Q3 -10% -94.7% -94.7% -29% -66.9% 8% -24.6% 21.8% -16.2% -
Q4 -26.7% -94.7% -94.7% -55% 743.1% 40.4% -33% 32.5% -35.4% -
J F M A M J J A S O N D
2024 -11.9% -4.2% -7% 0.9% - - - - - - - -
2023 10.4% -15.6% -21.1% 20% 12.5% 60.5% -3.1% -9.1% -4.8% -23.9% -12.7% -6.9%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    -66%-38%0%0%0%170%-51%-41%16%-17%-34%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.03 - - -0.23 -0.2 -0.03 -0.1 -0.09 -0.08
Q2 0.03 - - -0.21 -0.19 -0.12 -0.11 -0.07 -0.09
Q3 0.03 - - -0.15 -0.12 -0.12 -0.07 -0.06 -0.11
Q4 - - - -0.23 -0.61 -0.15 -0.11 -0.10 -
A 0.1 0 0 -0.8 -1.1 -0.42 -0.4 -0.32 -0.28

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022
Mar - - - - -
Jun - - - - -
Sep - - - - -
Dec 17.4 32.2 46.2 55 61.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 10.5 - 9.5 -1.8 -
Equity multiplier 0.1 - - - -